Experimental ALS Drug Triggers Social Media Hype, But Doctors Say Facts about GM604 Are Slim
July 2, 2015
Terry Heiman-Patterson, MD, a professor of neurology in the College of Medicine, was mentioned in a Neurology Today article about an experimental ALS drug and the hype it’s been getting on social media.
Related:
Drexel News is produced by
University Marketing and Communications.